CMI compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name

CMICummins Inc

Mkt capRevenueRevenue

PFEPfizer Inc

Mkt capRevenueRevenue

Compare

CMICummins Inc

PFEPfizer Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CMI

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.1%▼−1.99%×0.25

Q1 FY26±6.5%▲+2.76%×0.43

Feb 5 '26±5.9%▼−10.73%×1.81

Q3 FY25±6.5%▲+5.38%×0.83

PFE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±3.3%▲+1.52%×0.45

Q1 FY26±3.5%▲+0.57%×0.17

= impliedCMI realized, solidPFE realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Feb 3 '26

±3.2%

▼−3.34%

×1.03

Q3 FY25±4.2%▼−1.46%×0.36

CMICummins Inc

499.57▼−0.10%· post 501.40

Mkt cap$68.9BRevenue$9.5BQ2 FY26Revenue$33.7BFY25

PFEPfizer Inc

30.71▲+0.62%· post 31.03

ClosedNov 2 '26

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

Compare

ClosedNov 2 '26

CMICummins Inc

PFEPfizer Inc

499.57▼−0.10%post 501.40

Price

30.71▲+0.62%post 31.03

$68.9B

Mkt cap

$174.0B

Q2 FY26$9.5B

Revenue

$15.0BQ2 FY26

FY25$33.7B

Revenue

$62.6BFY25

CMI499.57▼−0.10%vsPFE30.71▲+0.62%ClosedNov 2 '26